MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | – | 19,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 10,366,120 | $8,926,000 | 0.45% |
| Clearline Capital LP | 3,957,135 | $3,407,000 | 0.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $6,342,000 | 0.26% |
| DAFNA Capital Management LLC | 1,096,513 | $944,000 | 0.25% |
| Privium Fund Management (UK) Ltd | 177,200 | $153,000 | 0.20% |
| Orbimed Advisors | 10,605,522 | $9,132,000 | 0.17% |
| Octagon Capital Advisors LP | 1,000,000 | $861,000 | 0.15% |
| Rock Springs Capital Management LP | 6,244,897 | $5,377,000 | 0.14% |
| Boxer Capital, LLC | 2,250,000 | $1,937,000 | 0.11% |
| Monaco Asset Management SAM | 186,656 | $161,000 | 0.06% |